125I episcleral plaque brachytherapy in the treatment of choroidal melanoma: A single-institution experience in Spain

Brachytherapy

Volumn 8, Issue 3, 2009, Pages 290-296

  Correa Generoso, Raquel ^a   Pera, Joan ^b   Gómez, Joaquín ^c   Polo, Alfredo ^d   Gutiérrez, Cristina ^b   Caminal, Josep María ^e   Modolell, Ignasi ^b   Navarro, Valenti ^b   Guedea, Ferrán ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c CROASA Clinic   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Brachytherapy; Choroidal melanoma; COMS; Episcleral plaque

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CHOROID MELANOMA; DOSIMETRY; ENUCLEATION; FOLLOW UP; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PATIENT CODING; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RETINA DETACHMENT; RETINOPATHY; SPAIN; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHOROID NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SPAIN;

EID: 67651026891     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.03.189     Document Type: Article

References (22)

1. Zimmerman L.E., McLean I.W., and Foster W.D. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol 62 (1978) 420-425
2. Curtis E. The Collaborative Ocular Melanoma Study: An overview. Cancer Control 11 (2004) 304-3091
3. Gass J.D. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol 103 (1985) 916-923
4. Cruess A.F., Augsburger J.J., Shields J.A., et al. Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy. Ophthalmology 91 (1984) 1716-1719
5. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS report No. 10. Am J Ophthalmol 125 (1998) 779-796
6. Diener-West M., Earle J.D., Fine S.L., et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma III: Initial mortality findings. COMS report No. 18. Arch Ophthalmol 119 (2001) 969-982
7. The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal elanoma: COMS report No. 5. Arch Ophthalmol 115 (1997) 1537-1544
8. Jensen A.W., Petersen I.A., Kline R.W., et al. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 63 (2005) 101-108
9. De Potter P., Shields C.L., Shields J.A., et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol 114 (1996) 1357-1365
10. Gunduz K., Shields C.L., Shields J.A., et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 127 (1999) 579-589
11. Shields C.L., Naseripour M., Cater J., et al. Plaque radiotherapy for large posterior uveal melanomas (≥8 mm thick) in 354 consecutive patients. Ophthalmology 109 (2002) 1838-1849
12. Heindl L.M., Lotter M., Strnad V., et al. High-dose (106)Ruthenium plaque brachytherapy for posterior uveal melanoma: A clinico-pathologic study. Ophthalmologe 104 (2007) 149-157
13. 106Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 63 (2005) 385-391
14. Petrovich Z., Luxton G., Langholz B., et al. Episcleral plaque radiotherapy in the treatment of uveal melanomas. Int J Radiat Oncol Biol Phys 24 (1992) 247-251
15. Jampol L.M., Moy C.S., Murray T.G., et al., Collaborative Ocular Melanoma Study Group (COMS Group). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 109 (2002) 2197-2206
16. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 124 (2006) 1684-1693
17. Nag S., Wang D., Wu H., et al. Custom-made "Nag" eye plaques for 125I brachytherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1373-1380
18. Moataz N., El-Ghamry M.D., Subir Nag M.D., et al. Results of primary treatment of small or medium sized uveal melanoma with custom-made Nag iodine-125 eye plaque: The Ohio State University experience with 119 patients. Brachytherapy 5 (2006) 90
19. Fontanesi J., Meyer D., Xu S., et al. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys 26 (1993) 619-623
20. Packer S., Stoller S., Lesser M.L., et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 99 (1992) 767-774
21. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. Visual acuity after 3 years. COMS Report No 16. Ophthalmology 108 (2001) 348-366
22. Caminal J.M., Quintana M., Pera J., et al. Results of iodine-125 radiotherapy in the treatment of uveal melanoma. Arch Soc Esp Oftalmol 77 (2002) 29-38